Search Results - "JOHNSON, Julie"

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update by Lee, Craig R., Luzum, Jasmine A., Sangkuhl, Katrin, Gammal, Roseann S., Sabatine, Marc S., Stein, Charles Michael, Kisor, David F., Limdi, Nita A., Lee, Yee Ming, Scott, Stuart A., Hulot, Jean‐Sébastien, Roden, Dan M., Gaedigk, Andrea, Caudle, Kelly E., Klein, Teri E., Johnson, Julie A., Shuldiner, Alan R.

“…CYP2C19 catalyzes the bioactivation of the antiplatelet prodrug clopidogrel, and CYP2C19 genotype impacts clopidogrel active metabolite formation. CYP2C19…”
Get full text

Cannabis Research and Therapeutics: An International Quasi-experiment in Cannabis Policy by Johnson, Julie K., Colby, Alexander

Get full text

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine by El Rouby, Nihal, Lima, John J, Johnson, Julie A

“…Proton Pump inhibitors (PPIs) are commonly used for a variety of acid related disorders. Despite the overall effectiveness and safety profile of PPIs, some…”
Get more information

Ethnic Differences in Cardiovascular Drug Response : Potential Contribution of Pharmacogenetics by JOHNSON, Julie A

Get full text

History of Cannabis Regulation and Medicinal Therapeutics: It's Complicated by Johnson, Julie K., Colby, Alexander

“…The genus Cannabis has a complex history, with great variations in the genus itself, as well as in its current uses worldwide. Today, it is the most commonly…”
Get full text

Association Between Surgeon Technical Skills and Patient Outcomes by Stulberg, Jonah J, Huang, Reiping, Kreutzer, Lindsey, Ban, Kristen, Champagne, Bradley J, Steele, Scott R, Johnson, Julie K, Holl, Jane L, Greenberg, Caprice C, Bilimoria, Karl Y

“…Postoperative complications remain common after surgery, but little is known about the extent of variation in operative technical skill and whether variation…”
Get more information

Warfarin pharmacogenetics: a rising tide for its clinical value by Johnson, Julie A

Get full text

A Point-of-Care Resource to Improve Care of Patients with Adrenal Mass: www.AdrenalMass.org by Strother, Marshall, Hallanger Johnson, Julie, Kutikov, Alexander

Get full text

CYP2D6 pharmacogenetics and phenoconversion in personalized medicine by Nahid, Noor A, Johnson, Julie A

“…CYP2D6 contributes to the metabolism of approximately 20-25% of drugs. However, is highly polymorphic and different alleles can lead to impacts ranging from…”
Get more information

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing by Lima, John J., Thomas, Cameron D., Barbarino, Julia, Desta, Zeruesenay, Van Driest, Sara L., El Rouby, Nihal, Johnson, Julie A., Cavallari, Larisa H., Shakhnovich, Valentina, Thacker, David L., Scott, Stuart A., Schwab, Matthias, Uppugunduri, Chakradhara Rao S., Formea, Christine M., Franciosi, James P., Sangkuhl, Katrin, Gaedigk, Andrea, Klein, Teri E., Gammal, Roseann S., Furuta, Takahisa

“…Proton pump inhibitors (PPIs) are widely used for acid suppression in the treatment and prevention of many conditions, including gastroesophageal reflux…”
Get full text

Warfarin pharmacogenetics by Johnson, Julie A, Cavallari, Larisa H

“…Abstract The cytochrome P450 (CYP) 2C9 and vitamin K epoxide reductase complex 1 (VKORC1) genotypes have been strongly and consistently associated with…”
Get full text

Short-term effects of ambient air pollution on stroke: Who is most vulnerable? by Villeneuve, Paul J., Johnson, Julie Y.M., Pasichnyk, Dion, Lowes, Justin, Kirkland, Scott, Rowe, Brian H.

“…Several studies have demonstrated positive associations between day-to-day increases in air pollution and stroke. These findings have been inconsistent, and…”
Get full text

Elucidating the Impact of Adolescent Marijuana Use by Johnson, Julie K.

Get full text

Tribute to Professor Hartmut Derendorf ‐ 1953 to 2020: Driving force in Clinical Pharmacology and Mentor Extraordinaire by Johnson, Julie A., Schmidt, Stephan

Get full text

Past 30–Day Marijuana Vaping: Prevalence and Predictors of Use in a Nationally Representative Study of U.S. Youth by Kritikos, Alexandra F., Johnson, Julie K., Hodgkin, Dominic

“…Vaping has become an increasingly common mode of administration for marijuana among youth, but there are limited data on its prevalence. There is a need to…”
Get full text

Pharmacogenetics and cardiovascular disease--implications for personalized medicine by Johnson, Julie A, Cavallari, Larisa H

“…The past decade has seen tremendous advances in our understanding of the genetic factors influencing response to a variety of drugs, including those targeted…”
Get full text

Pharmacogenetics in clinical practice: how far have we come and where are we going? by Johnson, Julie A

“…Recent years have seen great advances in our understanding of genetic contributors to drug response. Drug discovery and development around targeted genetic…”
Get more information

Gender Differences in Utilization of Duty-hour Regulations, Aspects of Burnout, and Psychological Well-being Among General Surgery Residents in the United States by Dahlke, Allison R, Johnson, Julie K, Greenberg, Caprice C, Love, Remi, Kreutzer, Lindsey, Hewitt, Daniel B, Quinn, Christopher M, Engelhardt, Kathryn E, Bilimoria, Karl Y

“…OBJECTIVE:The aim of the study was to (1) assess differences in how male and female general surgery residents utilize duty-hour regulations and experience…”
Get full text

Pharmacogenetic factors affecting β-blocker metabolism and response by Thomas, Cameron D, Johnson, Julie A

“…β-blockers are among the most widely prescribed of all drugs, used for treatment of a large number of cardiovascular diseases. Herein we evaluate literature…”
Get more information

Hypertension pharmacogenomics: in search of personalized treatment approaches by Cooper-DeHoff, Rhonda M., Johnson, Julie A.

“…Key Points Hypertension is an important, modifiable risk factor for cardiovascular and kidney disease Rates of blood pressure control are substantially below…”
Get full text